Related Experiment Video

Updated: Jun 28, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Pediatric facial trauma

Jeremy D Meier1, Travis T Tollefson

  • 1University of California, Davis Medical Center, Sacramento, CA 95817, USA.

Current Opinion in Otolaryngology & Head and Neck Surgery
|November 14, 2008
PubMed

Insights

Pediatric facial trauma is uncommon but can cause significant morbidity. Treatment is conservative, with specialized techniques for the growing pediatric skeleton, though resorbable plating is not yet standard.

Area of Science:

  • Pediatric surgery
  • Maxillofacial surgery
  • Trauma surgery

Background:

  • Pediatric facial trauma presents unique challenges due to the developing maxillofacial skeleton.
  • Literature often emphasizes injury patterns rather than management strategies.

Purpose of the Study:

  • Review the epidemiology, evaluation, and treatment of pediatric facial trauma.
  • Highlight unique challenges in managing these injuries in children.
  • Discuss current controversies in pediatric facial fracture management.

Main Methods:

  • Literature review focusing on epidemiology, evaluation, and treatment of pediatric facial trauma.
  • Analysis of current management strategies and controversies.
  • Emphasis on the pediatric craniofacial skeleton's unique characteristics.

Main Results:

  • Pediatric facial fractures are relatively uncommon but can lead to significant morbidity.
  • Treatment approaches are generally more conservative than in adults.
  • Open reduction and internal fixation may involve titanium or resorbable plating systems.
  • Resorbable plating systems show increasing use but are not standard of care.

Conclusions:

  • A comprehensive understanding of the pediatric maxillofacial skeleton is crucial for effective management.
  • Pediatric facial fractures require specialized consideration due to growth and development.
  • Timely and appropriate management can mitigate short-term and long-term morbidity.
Abstract

More Related Videos

Surgical Correction for Pediatric Epiblepharon and Trichiasis03:59

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Related Concept Videos

Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...